A Comprehensive Review on Medicinal Plants in Management of Polycystic Ovary Syndrome (Pcos) Related Problems, Clinical Manifestation and Therapeutic Potential of Medicinal Plants
Main Article Content
Abstract
Polycystic ovary syndrome (PCOS) is endocrine disorders affecting women of reproductive system, age and major cause of infertility, menstrual dysfunction, and metabolic abnormalities. This leads to hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology, insulin resistance and obesity. PCOS are increased risk of metabolic syndrome, type 2 diabetes mellitus and endometrial cancer. In this interaction between genetic, hormonal and metabolic abnormalities. Nowadays, management PCOS includes lifestyle modification, insulin-sensitizing agents, ovulation-inducing therapy and hormonal natural medicine. Improve reproductive and metabolic outcomes by the medicinal plants like cinnamon (Cinnamomum verum L.), Turmeric (curcuma longa L.), Spearmint (Mentha spicata L.), Aloe Vera (Aloe barbadensis L.) etc.
References
1. Mohamed SS, Allam AT, El-Alfy AN, El-Shiekh RA, Reda AM, Abd El Hafeez MS. Phytotherapy in Polycystic Ovary Syndrome Management: A Systematic Review. Chem Biodivers. 2025;22(11): e00982.
2. Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018; 182:27–36.
3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;19(1):41-47.
4. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592.
5. Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome. Hum Reprod Update. 2016;22(6):687-708.
13
6. Arentz S, Abbott JA, Smith CA, Bensoussan A. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complement Altern Med. 2014; 14:511.
7. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-18.
8. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016; 2:16057.
9.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
10.Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–88.
11. Grant P. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. Phytother Res. 2010;24(2):186–188.
12. Akdogan M, Ozguner M, Kocak A, Oncu M, Cicek E. Effects of spearmint on androgen levels in women with hirsutism. Phytother Res. 2007;21(5):444–447.
13. Disha NS, Kumar BSA. Understanding PCOD and PCOS: A Comparative Review of Causes, Differences, and Treatment Modalities. J Neonatal Surg. 2025; 14:6704.
14. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270-84.
15. Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JSE, Legro RS. Scientific statement on the diagnostic features, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev.
16. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.
17. Heshmati J, Moini A, Sepidarkish M, Morvaridzadeh M, Salehi M, Palmowski A, et al. Effects of curcumin supplementation on metabolic parameters in PCOS: systematic review and meta-analysis. Phytother Res. 2020;34(10):2494–2506.
18. Lopresti AL, Smith SJ, Drummond PD. Effects of Withania somnifera on stress and endocrine function. Medicine (Baltimore). 2019;98(37): e17186.
14
19. Gerhard I, Patek A, Monga B, Blank A, Gorkow C. Vitex agnus-castus in women with infertility and menstrual disorders. Phytomedicine. 1998;5(4):255–266.
20. Armanini D, Bonanni G, Palermo M. Reduction of serum testosterone in women by licorice. Steroids. 1999;64(11):763–766.
21. Nowak DA, Snyder DC, Brown AJ. Flaxseed supplementation and androgen reduction in PCOS: a case study. Curr Top Nutraceutical Res. 2007;5(4):177–181.
22. Mukherjee PK. Quality Control and Evaluation of Herbal Drugs. New Delhi: Elsevier; 2019.
23. Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. New York: Springer; 2007.
24. Bruneton J. Pharmacognosy, Phytochemistry, Medicinal Plants. 2nd ed. Paris: Lavoisier Publishing; 1999.
25. World Health Organization. WHO Monographs on Selected Medicinal Plants. Geneva: WHO; 1999–2009.
26. Duke JA. Handbook of Medicinal Herbs. 2nd ed. Boca Raton: CRC Press; 2002.
27.Azin F, Khazali H. Phytotherapy of polycystic ovary syndrome: a review. Int J Reprod Biomed. 2022;20(1):13–20.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.